In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis being a Schedule III drug. This rescheduling will acknowledge that cannabis has reputable medical uses and will help open the door to exploration on other prospective therapy uses. Go through future Organization Insider tells the https://thcdisposables.co.uk/